Saul Sterman is the CEO of CrossProfit, a company that researches and posts evaluation lines for over 1000 U.S. traded equities. Research and analysis performed on behalf of clients is proprietary and confidential and is not posted on the site without explicit written permission. Self initiated R&A is publicly disseminated within a reasonable time of notifying clients/associates. CrossProfit respects the fact that companies' analysts affiliated with CrossProfit are required to maintain anonymity. Most of the articles and comments written by CrossProfit are actually written by five analysts, but all articles are edited by Saul Sterman prior to posting and/or submission to SA. Any and all possible conflicts of interests are fully disclosed. All evaluation lines on the CrossProfit site are based on rigorous fundamental analysis. The website is geared more towards the individual investor and licensed financial advisor. Hedge funds and financial institutions aspiring to outsource research & analysis, requiring consultancy or seeking an independent second opinion may contact Mr. Sterman directly via facsimile at (011) 972 2 583 6468 or through the site's contact options. CrossProfit is a division of Precision Sciences Ltd. Visit the Cross Profit (http://www.crossprofit.com/) site.